As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Abstract: This paper introduces a novel method for estimating the path loss value in indoor scenarios. It uses a combination of electromagnetic calculation and machine learning. Using electromagnetic ...

A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable online pharmacies in search of weight loss drugs at ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Roku Inc.’s stock fell 12.5% in after-hours trade Wednesday, after the streaming platform posted another quarterly loss and flat average revenue per user. Roku ROKU posted a third-quarter net ...

“Is there a demand problem here? No,” he said. Still, the company will begin marketing Zepbound directly to consumers for the first time in a bid to boost sales. Weight-Loss Race Obesity is one of the ...

drugmaker GSK and building materials producer Holcim became the first companies to adopt science-based targets to protect nature established by a new group that aims to reduce biodiversity loss ...